{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:28:51Z","timestamp":1794947331436,"version":"4.9.1"},"reference-count":137,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019736","name":"Farmer Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurot.2025.e00791","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:26:43Z","timestamp":1763699203000},"page":"e00791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dietary tributyrin supplementation in Parkinson\u2019s disease: An open-label target engagement study"],"prefix":"10.1016","volume":"23","author":[{"given":"Jeffrey L.B.","family":"Bohnen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stiven","family":"Roytman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis P.","family":"Wigstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Vangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime E.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitasha","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabesh","family":"Kanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Albin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas I.","family":"Bohnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neurot.2025.e00791_bib1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/mds.23467","article-title":"Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson\u2019s disease","volume":"26","author":"Post","year":"2011","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00791_bib2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.parkreldis.2014.07.004","article-title":"Severity of mild cognitive impairment in early Parkinson\u2019s disease contributes to poorer quality of life","volume":"20","author":"Lawson","year":"2014","journal-title":"Parkinsonism Relat Disorders"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00791_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/ane.12375","article-title":"Cognitive function in the early phase of Parkinson\u2019s disease, a five-year follow-up","volume":"132","author":"Domell\u00f6f","year":"2015","journal-title":"Acta Neurol Scand"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00791_bib4","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e3181f39d0e","article-title":"Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis","volume":"75","author":"Aarsland","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00791_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00791_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/bs11040054","article-title":"Treatment of Parkinson\u2019s disease with cognitive impairment: current approaches and future directions","volume":"11","author":"Sun","year":"2021","journal-title":"Behav Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00791_bib7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mds.20324","article-title":"Sydney multicenter study of parkinson\u2019s disease: non-L-dopa-responsive problems dominate at 15 years","volume":"20","author":"Hely","year":"2005","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00791_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jnnp-2020-323939","article-title":"Prognostic predictors relevant to end-of-life palliative care in parkinson\u2019s disease and related disorders: a systematic review","volume":"92","author":"Akbar","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00791_bib9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.47.2.462","article-title":"Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease","volume":"47","author":"Albin","year":"1996","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00791_bib10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2967\/jnumed.111.089946","article-title":"Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study","volume":"52","author":"Bohnen","year":"2011","journal-title":"J Nucl Med"},{"issue":"16 Pt 2","key":"10.1016\/j.neurot.2025.e00791_bib11","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1212\/01.wnl.0000304050.05332.9c","article-title":"Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease","volume":"70","author":"Huang","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00791_bib12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.neuroimage.2006.09.003","article-title":"Metabolic brain networks associated with cognitive function in Parkinson\u2019s disease","volume":"34","author":"Huang","year":"2007","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00791_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/cns.12504","article-title":"The neural basis of postural instability Gait disorder subtype of Parkinson\u2019s Disease: a PET and fMRI study","volume":"22","author":"Zhang","year":"2016","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00791_bib14","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/mds.28977","article-title":"Gait-related metabolic covariance networks at rest in Parkinson\u2019s Disease","volume":"37","author":"Sigurdsson","year":"2022","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00791_bib15","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s10072-023-07273-y","article-title":"Hyperglycemia affects axial signs in patients with Parkinson\u2019s disease through mechanisms of insulin resistance or non-insulin resistance","volume":"45","author":"Wang","year":"2024","journal-title":"Neurol Sci"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00791_bib16","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1177\/0271678X20981502","article-title":"In vivo synaptic density relates to glucose metabolism at rest in healthy subjects, but is strongly modulated by regional differences","volume":"41","author":"van Aalst","year":"2021","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00791_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073627","article-title":"Synapses: the brain\u2019s energy-demanding sites","volume":"23","author":"Faria-Pereira","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00791_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1123290","article-title":"Ketogenic interventions in mild cognitive impairment, Alzheimer\u2019s disease, and Parkinson\u2019s disease: a systematic review and critical appraisal","volume":"14","author":"Bohnen","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurot.2025.e00791_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.exger.2017.07.004","article-title":"A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer\u2019s disease","volume":"107","author":"Croteau","year":"2018","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.neurot.2025.e00791_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2021.715811","article-title":"Synaptic density and neuronal Metabolic function measured by positron emission tomography in the unilateral 6-OHDA rat model of Parkinson\u2019s Disease","volume":"13","author":"Raval","year":"2021","journal-title":"Front Synaptic Neurosci"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00791_bib21","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1177\/0271678X211004312","article-title":"Comparison of [(11)C]UCB-J and [(18)F]FDG PET in Alzheimer\u2019s disease: a tracer kinetic modeling study","volume":"41","author":"Chen","year":"2021","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41531-024-00655-9","article-title":"Synaptic loss and its association with symptom severity in Parkinson\u2019s disease","volume":"10","author":"Holmes","year":"2024","journal-title":"npj Parkinson\u2019s Dis"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00791_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41583-024-00812-2","article-title":"Key genes and convergent pathogenic mechanisms in Parkinson disease","volume":"25","author":"Coukos","year":"2024","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00791_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/nu12030788","article-title":"Modulation of cellular biochemistry, epigenetics and metabolomics by ketone bodies. Implications of the ketogenic diet in the physiology of the organism and pathological States","volume":"12","author":"D\u0105bek","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.neurot.2025.e00791_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnins.2018.00155","article-title":"Interplay between the gut-brain axis, obesity and cognitive function","volume":"12","author":"Agust\u00ed","year":"2018","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41598-018-36941-9","article-title":"Prominent action of butyrate over \u03b2-hydroxybutyrate as histone deacetylase inhibitor, transcriptional modulator and anti-inflammatory molecule","volume":"9","author":"Chriett","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2025.e00791_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbr.2015.05.052","article-title":"Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: modulation of histone deacetylase activity","volume":"291","author":"Sharma","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neurot.2025.e00791_bib28","article-title":"Sodium butyrate ameliorates oxidative stress-induced intestinal epithelium barrier injury and mitochondrial damage through AMPK-Mitophagy pathway","volume":"2022","author":"Li","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.neurot.2025.e00791_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103092","article-title":"Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS\/RNS: relevance to Parkinson\u2019s disease and therapeutic implications","volume":"71","author":"Kalyanaraman","year":"2024","journal-title":"Redox Biol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00791_bib30","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1096\/fj.201700547RR","article-title":"Oral sodium butyrate impacts brain metabolism and hippocampal neurogenesis, with limited effects on gut anatomy and function in pigs","volume":"32","author":"Val-Laillet","year":"2018","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbr.2011.03.033","article-title":"Posttraining systemic administration of the histone deacetylase inhibitor sodium butyrate ameliorates aging-related memory decline in rats","volume":"221","author":"Reolon","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neurot.2025.e00791_bib32","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1038\/ncomms4611","article-title":"The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism","volume":"5","author":"Frost","year":"2014","journal-title":"Nat Commun"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00791_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/foods11182863","article-title":"Health benefits and side effects of short-chain fatty acids","volume":"11","author":"Xiong","year":"2022","journal-title":"Foods"},{"key":"10.1016\/j.neurot.2025.e00791_bib34","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.3389\/fimmu.2018.01832","article-title":"Butyrate and dietary soluble fiber improve neuroinflammation associated with aging in mice","volume":"9","author":"Matt","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40168-018-0439-y","article-title":"Microbiome-host systems interactions: protective effects of propionate upon the blood-brain barrier","volume":"6","author":"Hoyles","year":"2018","journal-title":"Microbiome"},{"key":"10.1016\/j.neurot.2025.e00791_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2025.173972","article-title":"Short-chain fatty acids in Huntington\u2019s disease: mechanisms of action and their therapeutic implications","volume":"249","author":"Saadh","year":"2025","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00791_bib37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/gut.40.3.400","article-title":"Oxidation of short and medium chain C2-C8 fatty acids in sprague-Dawley rat colonocytes","volume":"40","author":"J\u00f8rgensen","year":"1997","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00791_bib38","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/gut.37.5.684","article-title":"Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis","volume":"37","author":"Clausen","year":"1995","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00791_bib39","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s13311-019-00719-2","article-title":"Neuroprotection of fasting mimicking diet on MPTP-Induced Parkinson\u2019s Disease mice via Gut Microbiota and metabolites","volume":"16","author":"Zhou","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00791_bib40","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.nucmedbio.2013.06.007","article-title":"Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET","volume":"40","author":"Kim","year":"2013","journal-title":"Nucl Med Biol"},{"issue":"16","key":"10.1016\/j.neurot.2025.e00791_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168998","article-title":"Implications of butyrate signaling pathways on the motor symptomatology of Parkinson\u2019s Disease and neuroprotective effects-therapeutic approaches: a systematic review","volume":"25","author":"Missiego-Beltr\u00e1n","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00791_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109452","article-title":"Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice","volume":"341","author":"Jiang","year":"2021","journal-title":"Chem Biol Interact"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02566-18","article-title":"Dynamics of Human Gut Microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers","volume":"10","author":"Baxter","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.neurot.2025.e00791_bib44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neubiorev.2020.02.003","article-title":"Gut microbiota differences between healthy older adults and individuals with Parkinson\u2019s disease: a systematic review","volume":"112","author":"Nuzum","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00791_bib45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s003940070028","article-title":"Short-chain fatty acid (SCFA) uptake into Caco-2 cells by a pH-dependent and carrier mediated transport mechanism","volume":"39","author":"Stein","year":"2000","journal-title":"Eur J Nutr"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00791_bib46","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1113\/JP272613","article-title":"Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study","volume":"595","author":"Boets","year":"2017","journal-title":"J Physiol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00791_bib47","first-page":"1335","article-title":"Tributyrin induces growth inhibitory and differentiating effects on HT-29 colon cancer cells in vitro","volume":"13","author":"Schr\u00f6der","year":"1998","journal-title":"Int J Oncol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00791_bib48","first-page":"629","article-title":"Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors","volume":"4","author":"Conley","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00791_bib49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s002800050922","article-title":"Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats","volume":"43","author":"Egorin","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00791_bib50","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","article-title":"Improved accuracy of clinical diagnosis of lewy body Parkinson\u2019s disease","volume":"57","author":"Hughes","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2025.e00791_bib51","article-title":"Automated production of [(11)C]butyrate for keto body PET imaging","volume":"116\u2013117","author":"Pakula","year":"2023","journal-title":"Nucl Med Biol"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00791_bib52","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0969-8051(03)00114-8","article-title":"A review of graphical methods for tracer studies and strategies to reduce bias","volume":"30","author":"Logan","year":"2003","journal-title":"Nucl Med Biol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00791_bib53","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004647-200202000-00012","article-title":"Modified regression model for the logan plot","volume":"22","author":"Varga","year":"2002","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00791_bib54","article-title":"TotalSegmentator: robust segmentation of 104 anatomic structures in CT images","volume":"5","author":"Wasserthal","year":"2023","journal-title":"Radiology: Artif Intell"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41592-018-0235-4","article-title":"fMRIPrep: a robust preprocessing pipeline for functional MRI","volume":"16","author":"Esteban","year":"2019","journal-title":"Nat Methods"},{"key":"10.1016\/j.neurot.2025.e00791_bib56","article-title":"Nilearn (0.11.0)","author":"Nilearn contributors","year":"2024","journal-title":"Zenodo"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00791_bib57","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1152\/jn.00338.2011","article-title":"The organization of the human cerebral cortex estimated by intrinsic functional connectivity","volume":"106","author":"Thomas Yeo","year":"2011","journal-title":"J Neurophysiol"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00791_bib58","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1073\/pnas.1913042117","article-title":"Diet modulates brain network stability, a biomarker for brain aging, in young adults","volume":"117","author":"Mujica-Parodi","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00791_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133402","article-title":"Surface-Based display of volume-averaged cerebellar imaging data","volume":"10","author":"Diedrichsen","year":"2015","journal-title":"PLoS One"},{"issue":"6139","key":"10.1016\/j.neurot.2025.e00791_bib60","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1126\/science.1235381","article-title":"BigBrain: an ultrahigh-resolution 3D human brain model","volume":"340","author":"Amunts","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neurot.2025.e00791_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118274","article-title":"Myelo- and cytoarchitectonic microstructural and functional human cortical atlases reconstructed in common MRI space","volume":"239","author":"Pijnenburg","year":"2021","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12603-013-0003-1","article-title":"Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement","volume":"17","author":"Hampel","year":"2013","journal-title":"J Nutr Health Aging"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00791_bib63","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","article-title":"The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease","volume":"34","author":"Brakedal","year":"2022","journal-title":"Cell Metab"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00791_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/nu16193384","article-title":"A sustained-release butyrate tablet suppresses Ex vivo T helper cell activation of osteoarthritis patients in a double-blind placebo-controlled randomized trial","volume":"16","author":"Korsten","year":"2024","journal-title":"Nutrients"},{"issue":"15","key":"10.1016\/j.neurot.2025.e00791_bib65","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1096\/fj.00-0359fje","article-title":"Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production","volume":"14","author":"S\u00e4emann","year":"2000","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00791_bib66","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.47.3.397","article-title":"Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn\u2019s disease","volume":"47","author":"Segain","year":"2000","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00791_bib67","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.neuropharm.2012.01.028","article-title":"Contributions of central and systemic inflammation to the pathophysiology of Parkinson\u2019s disease","volume":"62","author":"Collins","year":"2012","journal-title":"Neuropharmacology"},{"issue":"15","key":"10.1016\/j.neurot.2025.e00791_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152416","article-title":"NADPH and mitochondrial quality control as targets for a circadian-based fasting and exercise therapy for the treatment of Parkinson\u2019s Disease","volume":"11","author":"Curtis","year":"2022","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00791_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071775","article-title":"Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease","volume":"10","author":"Salvi","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00791_bib70","first-page":"735","article-title":"Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells","volume":"117","author":"Mitchell","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurot.2025.e00791_bib71","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fncel.2019.00162","article-title":"Fatty acid signaling mechanisms in neural cells: fatty acid receptors","volume":"13","author":"Falomir-Lockhart","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"7268","key":"10.1016\/j.neurot.2025.e00791_bib72","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2025.e00791_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.656441","article-title":"Free fatty acid receptors as mediators and therapeutic targets in liver disease","volume":"12","author":"Secor","year":"2021","journal-title":"Front Physiol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00791_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063303","article-title":"Short-Chain fatty acid receptors and cardiovascular function","volume":"23","author":"Lymperopoulos","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00791_bib75","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1073\/pnas.1016088108","article-title":"Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)","volume":"108","author":"Kimura","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib76","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1148\/radiol.12112723","article-title":"Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET","volume":"265","author":"Wong","year":"2012","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00791_bib77","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2967\/jnumed.116.176891","article-title":"2-Year natural decline of cardiac sympathetic innervation in idiopathic parkinson disease studied with 11C-Hydroxyephedrine PET","volume":"58","author":"Wong","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.neurot.2025.e00791_bib78","article-title":"Cardiac sympathetic denervation and anxiety in Parkinson disease","volume":"124","author":"Carli","year":"2024","journal-title":"Parkinsonism Relat Disorders"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00791_bib79","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1007\/s00259-024-06822-7","article-title":"Noradrenergic cardiac denervation is associated with gait velocity in Parkinson disease: a dual ligand PET study","volume":"51","author":"Carli","year":"2024","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00791_bib80","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neures.2007.05.001","article-title":"Expression of free fatty acid receptor GPR40 in the central nervous system of adult monkeys","volume":"58","author":"Ma","year":"2007","journal-title":"Neurosci Res"},{"issue":"Pt B","key":"10.1016\/j.neurot.2025.e00791_bib81","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuropharm.2015.05.013","article-title":"The role of polyunsaturated fatty acids and GPR40 receptor in brain","volume":"113","author":"Khan","year":"2017","journal-title":"Neuropharmacology"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00791_bib82","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M211495200","article-title":"The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids","volume":"278","author":"Briscoe","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurot.2025.e00791_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101757","article-title":"Free fatty acid receptor 1 stimulates cAMP production and gut hormone secretion through Gq-mediated activation of adenylate cyclase 2","volume":"74","author":"Petersen","year":"2023","journal-title":"Mol Metabol"},{"issue":"34","key":"10.1016\/j.neurot.2025.e00791_bib84","doi-asserted-by":"crossref","first-page":"21131","DOI":"10.1074\/jbc.M115.644450","article-title":"\u03b2-Arrestin recruitment and biased agonism at free Fatty acid receptor 1","volume":"290","author":"Mancini","year":"2015","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00791_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj2384","article-title":"Structural basis for the ligand recognition and signaling of free fatty acid receptors","volume":"10","author":"Zhang","year":"2024","journal-title":"Sci Adv"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00791_bib86","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1124\/mol.112.079640","article-title":"Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor","volume":"82","author":"Lin","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00791_bib87","series-title":"SSCsobaoscfaoffar-Aca","author":"Sundaram","year":"2023"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00791_bib88","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.25430","article-title":"Cholinergic system changes of falls and freezing of gait in Parkinson\u2019s disease","volume":"85","author":"Bohnen","year":"2019","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00791_bib89","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab109","article-title":"Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson\u2019s disease","volume":"3","author":"Bohnen","year":"2021","journal-title":"Brain Commun"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00791_bib90","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1093\/brain\/awad134","article-title":"Cholinergic system correlates of postural control changes in Parkinson\u2019s disease freezers","volume":"146","author":"Roytman","year":"2023","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00791_bib91","doi-asserted-by":"crossref","DOI":"10.1088\/1741-2552\/ab20bc","article-title":"Maximal flexibility in dynamic functional connectivity with critical dynamics revealed by fMRI data analysis and brain network modelling","volume":"16","author":"Song","year":"2019","journal-title":"J Neural Eng"},{"key":"10.1016\/j.neurot.2025.e00791_bib92","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.neuroimage.2018.08.026","article-title":"Critical dynamics, anesthesia and information integration: lessons from multi-scale criticality analysis of voltage imaging data","volume":"183","author":"Fekete","year":"2018","journal-title":"Neuroimage"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00791_bib93","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.tics.2019.04.002","article-title":"Neuromodulatory influences on integration and segregation in the brain","volume":"23","author":"Shine","year":"2019","journal-title":"Trends Cognit Sci"},{"key":"10.1016\/j.neurot.2025.e00791_bib94","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuint.2016.06.011","article-title":"The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis?","volume":"99","author":"Stilling","year":"2016","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib95","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1152\/physrev.00041.2018","article-title":"Free fatty acid receptors in health and disease","volume":"100","author":"Kimura","year":"2020","journal-title":"Physiol Rev"},{"issue":"24","key":"10.1016\/j.neurot.2025.e00791_bib96","doi-asserted-by":"crossref","first-page":"12181","DOI":"10.1039\/D1FO02116H","article-title":"A new paradigm for a new simple chemical: butyrate & immune regulation","volume":"12","author":"Dang","year":"2021","journal-title":"Food Funct"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3945\/jn.111.148155","article-title":"Butyrate activates the cAMP-protein kinase A-cAMP response element-binding protein signaling pathway in Caco-2 cells","volume":"142","author":"Wang","year":"2012","journal-title":"J Nutr"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00791_bib98","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1113\/JP275709","article-title":"Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals","volume":"596","author":"Myette-C\u00f4t\u00e9","year":"2018","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00791_bib99","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/jn\/nxaa417","article-title":"Acute nutritional ketosis and its implications for plasma glucose and glucoregulatory peptides in adults with prediabetes: a crossover placebo-controlled randomized trial","volume":"151","author":"Bharmal","year":"2021","journal-title":"J Nutr"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00791_bib100","doi-asserted-by":"crossref","first-page":"e1738","DOI":"10.1210\/clinem\/dgaa925","article-title":"14-Day ketone supplementation lowers glucose and improves vascular function in obesity: a randomized crossover trial","volume":"106","author":"Walsh","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00791_bib101","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1055\/s-0043-119089","article-title":"Effect of butyrate and inulin supplementation on glycemic status, lipid profile and glucagon-like peptide 1 level in patients with type 2 diabetes: a randomized Double-blind, placebo-controlled trial","volume":"49","author":"Roshanravan","year":"2017","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00791_bib102","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1179\/147683008X301540","article-title":"Acute effects of the very low carbohydrate diet on sleep indices","volume":"11","author":"Afaghi","year":"2008","journal-title":"Nutr Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00791_bib103","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MED.0000000000000660","article-title":"The therapeutic properties of ketogenic diets, slow-wave sleep, and circadian synchrony","volume":"28","author":"O\u2019Hearn","year":"2021","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00791_bib104","first-page":"350","article-title":"Butyric acid in irritable bowel syndrome","volume":"8","author":"Za\u0142\u0119ski","year":"2013","journal-title":"Przegl\u0105d Gastroenterol"},{"key":"10.1016\/j.neurot.2025.e00791_bib105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.intimp.2017.07.023","article-title":"Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner","volume":"51","author":"Lee","year":"2017","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00791_bib106","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jnutbio.2011.01.007","article-title":"Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis","volume":"23","author":"Vieira","year":"2012","journal-title":"J Nutr Biochem"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00791_bib107","article-title":"Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease","volume":"32","author":"Facchin","year":"2020","journal-title":"Neuro Gastroenterol Motil"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11734-8","article-title":"Butyrate-producing bacteria supplemented in vitro to Crohn\u2019s disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity","volume":"7","author":"Geirnaert","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00791_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/nu15102275","article-title":"Gut microbial metabolite butyrate and its therapeutic role in inflammatory bowel disease: a literature review","volume":"15","author":"Recharla","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib110","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1080\/21655979.2021.1985815","article-title":"Evidence for the butyrate metabolism as key pathway improving ulcerative colitis in both pediatric and adult patients","volume":"12","author":"Zhou","year":"2021","journal-title":"Bioengineered"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00791_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28114392","article-title":"Gut protective effect from D-Methionine or butyric acid against DSS and carrageenan-induced ulcerative colitis","volume":"28","author":"Ikeda","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib112","first-page":"28","article-title":"The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome","volume":"17","author":"Lewandowski","year":"2022","journal-title":"Przegl\u0105d Gastroenterol"},{"key":"10.1016\/j.neurot.2025.e00791_bib113","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ebiom.2018.03.030","article-title":"Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model","volume":"30","author":"Chen","year":"2018","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00791_bib114","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2036.2005.02639.x","article-title":"Oral butyrate for mildly to moderately active Crohn\u2019s disease","volume":"22","author":"Di Sabatino","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00791_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084148","article-title":"Biomarker of neuroinflammation in Parkinson\u2019s Disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin Geriatr Med"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00791_bib117","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1021\/acs.jafc.8b06208","article-title":"Dietary tributyrin attenuates intestinal inflammation, enhances mitochondrial function, and induces mitophagy in piglets challenged with diquat","volume":"67","author":"Wang","year":"2019","journal-title":"J Agric Food Chem"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00791_bib118","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1093\/jas\/skz187","article-title":"Butyrate promotes slow-twitch myofiber formation and mitochondrial biogenesis in finishing pigs via inducing specific microRNAs and PGC-1\u03b1 expression1","volume":"97","author":"Zhang","year":"2019","journal-title":"J Anim Sci"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00791_bib119","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","volume":"58","author":"Gao","year":"2009","journal-title":"Diabetes"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00791_bib120","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1523\/JNEUROSCI.6094-08.2009","article-title":"Na,K-ATPase activity regulates AMPA receptor turnover through proteasome-mediated proteolysis","volume":"29","author":"Zhang","year":"2009","journal-title":"J Neurosci"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00791_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/nu15133068","article-title":"Ketogenic-mimicking diet as a therapeutic modality for bipolar disorder: biomechanistic rationale and protocol for a pilot clinical trial","volume":"15","author":"Bohnen","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46776-8","article-title":"Ketone body \u03b2-hydroxybutyrate (BHB) preserves mitochondrial bioenergetics","volume":"13","author":"Llorente-Folch","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00791_bib123","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI200318797","article-title":"D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease","volume":"112","author":"Tieu","year":"2003","journal-title":"J Clin Investig"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00791_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176255","article-title":"Ketones elicit distinct alterations in adipose mitochondrial bioenergetics","volume":"21","author":"Walton","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"44","key":"10.1016\/j.neurot.2025.e00791_bib125","doi-asserted-by":"crossref","first-page":"24400","DOI":"10.1021\/acs.jafc.4c04456","article-title":"Butyrate inhibits the HDAC8\/NF-\u03baB pathway to enhance Slc26a3 expression and improve the intestinal epithelial barrier to relieve colitis","volume":"72","author":"Peng","year":"2024","journal-title":"J Agric Food Chem"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00791_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/nu15122760","article-title":"Butyrate protects barrier integrity and suppresses immune activation in a Caco-2\/PBMC Co-Culture model while HDAC inhibition mimics butyrate in restoring cytokine-induced barrier disruption","volume":"15","author":"Korsten","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00791_bib127","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56132-4","article-title":"Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome","volume":"9","author":"Nozu","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00791_bib128","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1104\/pp.104.3.865","article-title":"The synthesis of [gamma]-Aminobutyric acid in response to treatments reducing cytosolic pH","volume":"104","author":"Crawford","year":"1994","journal-title":"Plant Physiol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00791_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076617","article-title":"Gut Microbiota metabolites differentially release gliotransmitters from the cultured human astrocytes: a preliminary report","volume":"24","author":"Karbownik","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00791_bib130","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/gutjnl-2017-314050","article-title":"Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.neurot.2025.e00791_bib131","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbi.2024.01.010","article-title":"Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson\u2019s disease: a bench-to-bedside translational approach","volume":"117","author":"Liu","year":"2024","journal-title":"Brain Behav Immun"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00791_bib132","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/mds.29128","article-title":"Bacterial butyrate in Parkinson\u2019s Disease is linked to epigenetic changes and depressive symptoms","volume":"37","author":"Xie","year":"2022","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00791_bib133","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1111\/ene.15671","article-title":"Gut microbiota dysbiosis in Parkinson disease: a systematic review and pooled analysis","volume":"30","author":"Kleine","year":"2023","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00791_bib134","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/ene.14644","article-title":"Gut microbiota and metabolome distinctive features in Parkinson disease: focus on levodopa and levodopa-carbidopa intrajejunal gel","volume":"28","author":"Melis","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurot.2025.e00791_bib135","article-title":"Effect of dopaminergic medications on Montreal Cognitive Assessment in Parkinson\u2019s disease patients","volume":"138","author":"Xie","year":"2025","journal-title":"Parkinsonism Relat Disorders"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00791_bib136","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1017\/cjn.2018.21","article-title":"Effects of antiparkinson medication on cognition in Parkinson\u2019s Disease: a systematic review","volume":"45","author":"Roy","year":"2018","journal-title":"Can J Neurol Sci"},{"issue":"Pt 6","key":"10.1016\/j.neurot.2025.e00791_bib137","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/brain\/119.6.2121","article-title":"Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson\u2019s disease patients at different levodopa plasma levels","volume":"119","author":"Kulisevsky","year":"1996","journal-title":"Brain"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:53:39Z","timestamp":1775181219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925002697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":137,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1878747925002697"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00791","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dietary tributyrin supplementation in Parkinson\u2019s disease: An open-label target engagement study","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00791"}}